Roxane's Oral Morphine Sulfate Gets FDA Approval, But Also Inventory Oversight
Boehringer Ingelheim's Roxane Laboratories is the latest beneficiary of FDA's Unapproved Drugs Initiative.
Boehringer Ingelheim's Roxane Laboratories is the latest beneficiary of FDA's Unapproved Drugs Initiative.